K243933

Substantially Equivalent

Ceevra Reveal 3+

Applicant: Ceevra, Inc.
Product code: QIH
Advisory panel: Radiology
Date received: 2024-12-20
Decision date: 2025-03-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Francisco, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.